Axis Securities has an overweight call on Lupin with a target price of Rs 2600. The current market price of Lupin is Rs 2160. Lupin, incorporated in 1983, is a Large Cap company with a market cap of Rs 99094.85 crore, operating in the pharmaceuticals sector.
Lupin's key products/revenue segments include Pharmaceuticals, Other Services, Export Incentives, Other Operating Revenue and Scrap for the year ending 31-Mar-2024.
Financials For the quarter ended 30-09-2024, the company has reported a Consolidated Total Income of Rs 5715.02 crore, up .83% from last quarter Total Income of Rs 5668.11 crore and up 12.52% from last year same quarter Total Income of Rs 5078.96 crore. The company has reported net profit after tax of Rs 859.48 crore in the latest quarter.
The company's top management includes Mrs.Manju D Gupta, Mr.Jeffrey Kindler, Mr.Jean-Luc Belingard, Dr.Punita Kumar-Sinha, Mr.Mark D McDade, Mr.Ramesh Swaminathan, Ms.Vinita Gupta, Mr.Nilesh D Gupta, Mrs.Manju D Gupta, Mr.Alfonso Zulueta, Mr.Jeffrey Kindler, Mr.Jean-Luc Belingard, Dr.Punita Kumar-Sinha, Mr.Mark D McDade, Mr.Ramesh Swaminathan, Ms.Vinita Gupta, Mr.Nilesh D Gupta, Mr.Alfonso Zulueta. Company has B S R & Co. LLP as its auditors. As on 30-09-2024, the company has a total of 46 Crore shares outstanding.
Stock Trading
Masterclass on Value Investing and Company Valuation
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock Trading
Technical Analysis for Everyone —